DMAC · DiaMedica Therapeutics Inc.
$6.68
-0.07 (-1.04%)
At close · Aug 14
Market Cap
$360.22M
Shares
53.93M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-08-12 | — | $100,000,000 | $86,200,000 as of 2026-06-03 | — | 10-Q , filed 2026-08-10 |